[1] Forgiarini LA Jr, Grün G, Kretzmann NA,et al.When is injury potentially reversible in a lung ischemia-reperfusion model. J Surg Res. 2013;179(1):168-174.
[2] Venuta F, Diso D, Anile M, et al. Evolving techniques and perspectives in lung transplantation.Transplant Proc. 2005; 37(6):2682-2683.
[3] Linfert D, Chowdhry T, Rabb H. Lymphocytes and ischemia-reperfusion injury.Transplant Rev (Orlando). 2009; 23(1):1-10.
[4] Christie JD, Edwards LB, Aurora P,et al.The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009.J Heart Lung Transplant. 2009; 28(10):1031-1049.
[5] Grichnik KP, D'Amico TA.Acute lung injury and acute respiratory distress syndrome after pulmonary resection.Semin Cardiothorac Vasc Anesth. 2004;8(4): 317-334.
[6] Ng CS, Wan S, Yim AP,et al. Pulmonary dysfunction after cardiac surgery.Chest. 2002;121(4):1269-1277.
[7] Cour M, Gomez L, Mewton N,et al.Postconditioning: from the bench to bedside.J Cardiovasc Pharmacol Ther. 2011;16(2): 117-130.
[8] Steen S, Sjöberg T, Massa G,et al.Safe pulmonary preservation for 12 hours with low-potassium-dextran solution.Ann Thorac Surg. 1993;55(2):434-440.
[9] Kelly RF, Murar J, Hong Z,et al. Low potassium dextran lung preservation solution reduces reactive oxygen species production.Ann Thorac Surg. 2003;75(6):1705- 1710.
[10] Bando T, Albes JM, Fehrenbach H,et al. Influence of the potassium concentration on functional and structural preservation of the lung: where is the optimum.J Heart Lung Transplant. 1998;17(7):715-724.
[11] Müller C, Bittmann I, Hatz R,et al.Improvement of lung preservation -- from experiment to clinical practice.Eur Surg Res. 2002;34(1-2):77-82.
[12] Strüber M, Hohlfeld JM, Fraund S,et al.Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function.J Thorac Cardiovasc Surg. 2000; 120(3):566-572.
[13] Gámez P, Córdoba M, Millán I,et al. Improvements in lung preservation: 3 years' experience with a low-potassium dextran solution.Arch Bronconeumol. 2005;41(1):16-19.
[14] Strüber M, Wilhelmi M, Harringer W,et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation.Eur J Cardiothorac Surg. 2001; 19(2):190-194.
[15] Chu Y, Wu YC, Chou YC,et al.Endothelium-dependent relaxation of canine pulmonary artery after prolonged lung graft preservation in University of Wisconsin solution: role of L-arginine supplementation.J Heart Lung Transplant. 2004; 23(5):592-598.
[16] Khan FA, Maalik A, Iqbal Z,et al.Recent pharmacological developments in β-carboline alkaloid "harmaline".Eur J Pharmacol. 2013;721(1-3):391-394.
[17] Cao R, Peng W, Wang Z, et al.beta-Carboline alkaloids: biochemical and pharmacological functions.Curr Med Chem. 2007;14(4):479-500.
[18] Berrougui H, Martín-Cordero C, Khalil A,et al.Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta.Pharmacol Res. 2006; 54(2):150-157.
[19] Moura DJ, Richter MF, Boeira JM,et al.Antioxidant properties of beta-carboline alkaloids are related to their antimutagenic and antigenotoxic activities.Mutagenesis. 2007;22(4): 293-302.
[20] Chen YF, Kuo PC, Chan HH,et al.β-carboline alkaloids from Stellaria dichotoma var. lanceolata and their anti-inflammatory activity.J Nat Prod. 2010;73(12):1993-1998.
[21] Yamazaki Y, Kawano Y.Inhibitory effects of herbal alkaloids on the tumor necrosis factor-α and nitric oxide production in lipopolysaccharide-stimulated RAW264 macrophages.Chem Pharm Bull (Tokyo). 2011;59(3):388-391.
[22] Bi W, Bi Y, Xue P,et al.Novel β-carboline-tripeptide conjugates attenuate mesenteric ischemia/reperfusion injury in the rat.Eur J Med Chem. 2011;46(6):2441-2452.
[23] Murata T, Nakazawa H, Mori I,et al.Reperfusion after a two-hour period of pulmonary artery occlusion causes pulmonary necrosis.Am Rev Respir Dis. 1992;146(4):1048- 1053.
[24] McCord JM.Oxygen-derived free radicals in postischemic tissue injury.N Engl J Med. 1985;312(3):159-163.
[25] Grichnik KP, D'Amico TA.Acute lung injury and acute respiratory distress syndrome after pulmonary resection.Semin Cardiothorac Vasc Anesth. 2004;8(4):317-334.
[26] Klass O, Fischer UM, Antonyan A,et al.Pneumocyte apoptosis induction during cardiopulmonary bypass: effective prevention by radical scavenging using N-acetylcysteine.J Invest Surg. 2007;20(6):349-356.
[27] Page AB, Owen CR, Kumar R,et al.Persistent eIF2alpha(P) is colocalized with cytoplasmic cytochrome c in vulnerable hippocampal neurons after 4 hours of reperfusion following 10-minute complete brain ischemia.Acta Neuropathol. 2003; 106(1):8-16.
[28] Tapuria N, Kumar Y, Habib MM,et al.Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review.J Surg Res. 2008;150(2):304-330.
[29] de Perrot M, Liu M, Waddell TK, et al. Ischemia-reperfusion-induced lung injury.Am J Respir Crit Care Med. 2003;167(4):490-511.
[30] Snell GI, Levvey BJ, Zheng L,et al.Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.J Heart Lung Transplant. 2007; 26(7):669-674.
[31] Miyamoto M, Prause O, Sjöstrand M, et al.Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways.J Immunol. 2003;170(9):4665-4672.
[32] Yoshida S, Haque A, Mizobuchi T,et al.Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.Am J Transplant. 2006;6(4):724-735.
[33] Sharma AK, LaPar DJ, Zhao Y, et al.Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury.Am J Respir Crit Care Med. 2011 ;183(11):1539-1549.
[34] Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al.The role of interleukin-17 during acute rejection after lung transplantation.Eur Respir J. 2006;27(4):779-787.
[35] Loong CC, Hsieh HG, Lui WY, et al.Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection.J Pathol. 2002;197(3):322-332.
[36] Lindén A, Laan M, Anderson GP.Neutrophils, interleukin-17A and lung disease.Eur Respir J. 2005;25(1):159-172.
[37] Yao Z, Painter SL, Fanslow WC,et al.Human IL-17: a novel cytokine derived from T cells.J Immunol. 1995;155(12): 5483-5486.
[38] Laan M, Cui ZH, Hoshino H, et al.Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.J Immunol. 1999;162(4):2347-2352.
[39] Rahman MS, Yang J, Shan LY,et al.IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism.Clin Immunol. 2005;115(3):268-276.
[40] Albanesi C, Cavani A, Girolomoni G.IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.J Immunol. 1999;162(1):494-502.
[41] Ye P, Rodriguez FH, Kanaly S,et al.Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.J Exp Med. 2001;194(4): 519-527.
[42] Jones CE, Chan K.Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells.Am J Respir Cell Mol Biol. 2002;26(6):748-753.
[43] Laan M, Palmberg L, Larsson K,et al.Free, soluble interleukin-17 protein during severe inflammation in human airways.Eur Respir J. 2002;19(3):534-537.
[44] Molet S, Hamid Q, Davoine F,et al.IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.J Allergy Clin Immunol. 2001;108(3):430-438.
[45] Khimenko PL, Bagby GJ, Fuseler J,et al.Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs.J Appl Physiol (1985). 1998;85(6):2005-2011.
[46] Cerami A.Inflammatory cytokines.Clin Immunol Immunopathol. 1992;62(1 Pt 2):S3-10.
[47] Yoshizumi M, Kurihara H, Morita T,et al. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells.Biochem Biophys Res Commun. 1990; 166(1):324-329.
[48] Yamashita M, Schmid RA, Ando K,et al.Nitroprusside ameliorates lung allograft reperfusion injury.Ann Thorac Surg. 1996;62(3):791-796.
[49] Jahaniani F, Ebrahimi SA, Rahbar-Roshandel N,et al. Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent.Phytochemistry. 2005;66(13):1581-1592.
[50] Schwarz MJ, Houghton PJ, Rose S,et al.Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.Pharmacol Biochem Behav. 2003;75(3): 627-633.
[51] Farouk L, Laroubi A, Aboufatima R,et al.Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: possible mechanisms involved.J Ethnopharmacol. 2008; 115(3):449-454.
[52] Astulla A, Zaima K, Matsuno Y.Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities.J Nat Med. 2008;62(4):470-472.
[53] Arshad N, Neubauer C, Hasnain S,et al.Peganum harmala can minimize Escherichia coli infection in poultry, but long-term feeding may induce side effects.Poult Sci. 2008; 87(2):240-249.
[54] Zheng XY, Zhang ZJ, Chou GX,et al.Acetylcholinesterase inhibitive activity-guided isolation of two new alkaloids from seeds of Peganum nigellastrum Bunge by an in vitro TLC- bioautographic assay.Arch Pharm Res. 2009;32(9):1245- 1251.
[55] Toledo-Pereyra LH, Hau T, Simmons RL,et al.Lung preservation techniques.Ann Thorac Surg. 1977;23(5): 487-494.
[56] Hausen B, Ramsamooj R, Hewitt CW,et al.The importance of static lung inflation during organ storage: the impact of varying ischemic intervals in a double lung rat transplantation model.Transplantation. 1996;62(12):1720-1725.
[57] Kofidis T, Strüber M, Warnecke G,et al.Antegrade versus retrograde perfusion of the donor lung: impact on the early reperfusion phase.Transpl Int. 2003;16(11):801-805.
[58] Roe DW, Fehrenbacher JW, Niemeier MR,et al.Lung preservation: pulmonary flush route affects bronchial mucosal temperature and expression of IFN-gamma and Gro in regional lymph nodes.Am J Transplant. 2005;5(5):995-1001. |